We are live on ! Find out more
LGND icon

Ligand Pharmaceuticals
LGND

116 hedge funds and large institutions have $640M invested in Ligand Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 116 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less call options, than puts

Call options by funds: $4.19M | Put options by funds: $4.33M

Holders
116
Holders Change
+116
Holders Change %
–
% of All Funds
3.79%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
116
Increased
–
Reduced
–
Closed
–
Calls
$4.19M
Puts
$4.33M
Net Calls
-$140K
Net Calls Change
-$140K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
101
Tower Research Capital (TRC)
New York
$86K +$66.4K +3,690 New
First Manhattan
102
First Manhattan
New York
$69K +$42.2K +2,348 New
Bank of Montreal
103
Bank of Montreal
Ontario, Canada
$52K +$39.9K +2,217 New
Teacher Retirement System of Texas
104
Teacher Retirement System of Texas
Texas
$46K +$35.3K +1,962 New
BG
105
BlackRock Group
United Kingdom
$42K +$32.4K +1,803 New
Dimensional Fund Advisors
106
Dimensional Fund Advisors
Texas
$32K +$24.5K +1,364 New
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$19K +$14.2K +789 New
SSG
108
Summit Securities Group
New York
$19K +$14.4K +802 New
BlackRock
109
BlackRock
New York
$18K +$13.5K +750 New
Creative Planning
110
Creative Planning
Kansas
$9K +$7.18K +399 New
CAM
111
ClariVest Asset Management
California
$8K +$5.88K +327 New
Citigroup
112
Citigroup
New York
$7K +$5.22K +290 New
GT
113
Glenmede Trust
Pennsylvania
$7K +$5.7K +317 New
FA
114
Financial Advantage
Maryland
$6K +$4.32K +240 New
TWA
115
TCI Wealth Advisors
Arizona
$3K +$2.14K +119 New
CTC
116
Central Trust Company
Missouri
$1K +$1.01K +56 New
1 2 3 4
5

LGND Hedge Fund Activity: Q2 2013 in Review

116 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ligand Pharmaceuticals (LGND) for Q2 2013, worth a combined $640M.

Buyers outnumbered sellers: 116 funds opened new LGND positions and 0 closed out — a net gain of 116 holders — while 0 added to existing stakes and 0 trimmed.

  • 116 institutional investors held Ligand Pharmaceuticals (LGND) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $640M of Ligand Pharmaceuticals stock for Q2 2013.
  • 116 funds opened new Ligand Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +116 holders.

Based on aggregated 13F filings for Q2 2013.